Metronidazole Dosing in Pediatric Patients
For most pediatric infections in children over 1 month of age, administer metronidazole 30–40 mg/kg/day divided every 8 hours, with a maximum single dose of 500 mg, for a standard 10-day course. 1
Standard Dosing by Age Group
Neonates (≤1 month)
Neonatal dosing is weight- and age-dependent due to immature hepatic metabolism: 1
- Postnatal age ≤7 days, weight ≤2000 g: 7.5 mg/kg every 12 hours 1
- Postnatal age ≤7 days, weight >2000 g: 7.5–10 mg/kg every 12 hours 1
- Postnatal age >7 days, weight <1200 g: 7.5–10 mg/kg every 8–12 hours 1
- Postnatal age >7 days, weight >2000 g: 10 mg/kg every 8 hours 1
The prolonged half-life in preterm neonates (22.5–109 hours, inversely related to gestational age) necessitates less frequent dosing. 2 A loading dose of 15 mg/kg IV provides adequate levels for 48 hours in preterm infants and 24 hours in term infants. 2
Infants and Children (>1 month)
The standard regimen is 30–40 mg/kg/day divided every 8 hours (approximately 10–13 mg/kg per dose), with no single dose exceeding 500 mg. 1, 3
Condition-Specific Dosing
Clostridioides difficile Infection (CDI)
Metronidazole is no longer first-line therapy for CDI; oral vancomycin or fidaxomicin should be prioritized. 1, 4 When these agents are unavailable:
- Non-severe CDI (initial episode or first recurrence): 7.5 mg/kg/dose 3–4 times daily (maximum 500 mg/dose) for 10 days 5, 1
- Severe or fulminant CDI: Oral vancomycin is strongly preferred (strong recommendation, moderate-quality evidence). 5 If IV therapy is required due to ileus, give metronidazole 10 mg/kg/dose three times daily (maximum 500 mg/dose) combined with oral or rectal vancomycin—never as monotherapy. 5, 1
Critical pitfall: Recognize that CDI dosing (7.5 mg/kg/dose) is lower than dosing for other anaerobic infections (10–13 mg/kg/dose). 1
Intra-Abdominal Infections
Metronidazole must never be used as monotherapy for intra-abdominal infections. 1, 4 Administer 30–40 mg/kg/day divided every 8 hours always combined with gram-negative/aerobic coverage (aminoglycosides, carbapenems, or advanced-generation cephalosporins). 1
For severe infections with undrained abscesses, maximize the dose within the 30–40 mg/kg range. 1 Recent pharmacokinetic data support that 30 mg/kg once daily achieves adequate AUC/MIC ratios for Bacteroides fragilis (MIC ≤2 mcg/mL) in pediatric appendicitis, though traditional every-8-hour dosing remains guideline-recommended. 6
Necrotizing Infections
For mixed necrotizing infections requiring anaerobic coverage, use 7.5 mg/kg/dose every 6 hours IV, typically combined with cefotaxime (50 mg/kg/dose every 6 hours) or other broad-spectrum agents. 1
Amebiasis
For confirmed intestinal amebiasis: 30 mg/kg/day divided into three doses (approximately 10 mg/kg every 8 hours) for 5–10 days. 1, 3 For a 5 kg infant, this equals 50 mg every 8 hours (150 mg total daily dose). 1
Treatment should only be initiated after microscopic confirmation of amebic trophozoites in fresh stool. 1 If no clinical improvement occurs within 5–7 days, reassess the diagnosis—metronidazole-resistant amebiasis is rare, and misdiagnosis (e.g., bacterial dysentery) is common. 1
Perianal Fistulizing Crohn's Disease
Administer 10–20 mg/kg/day in divided doses. 1, 4 Ciprofloxacin 20 mg/kg/day is an alternative or adjunctive option. 1
Route of Administration
Oral administration is preferred when the patient can tolerate it. 1 IV administration is indicated for: 1
- Fulminant CDI with ileus (when oral intake is impossible)
- Severe necrotizing infections requiring rapid high tissue levels
- Patients unable to tolerate oral medication
Treatment Duration and Safety Warnings
Standard treatment duration is 10 days for most infections. 1, 4 Amebiasis may be treated for 5–10 days. 1
Neurotoxicity Risk
Courses longer than 10 days markedly increase the risk of cumulative, potentially irreversible neurotoxicity (peripheral neuropathy, seizures, encephalopathy). 1, 4, 7 Patients receiving therapy beyond 10 days should be closely monitored for neurological symptoms. 1, 7
Do not continue metronidazole beyond 10 days without a compelling clinical indication. 1, 4
Special Populations
Malnourished Children
Severely malnourished children demonstrate significantly prolonged elimination half-life (median 10.21 hours vs. 5.09 hours in rehabilitated children) and reduced metabolic clearance. 8 Dose reduction and individualized therapeutic regimens are necessary in this population. 8
Hepatic Impairment
In children with hepatic dysfunction, dose adjustment may be required, though specific pediatric guidance is limited. 1 Metronidazole is metabolized slowly in severe hepatic disease, leading to accumulation. 3
Renal Impairment
No adjustment of the parent drug dose is required because metronidazole pharmacokinetics are not altered by renal impairment. 4 Accumulated metabolites may be rapidly removed by dialysis. 3
Critical Clinical Pitfalls
- Never exceed 500 mg per single dose regardless of weight-based calculations 1, 4
- Never use metronidazole as monotherapy for intra-abdominal infections—always pair with gram-negative/aerobic coverage 1, 4
- Do not select metronidazole as first-line therapy for CDI—prioritize vancomycin or fidaxomicin 1, 4
- Avoid empiric use in undifferentiated acute diarrhea—metronidazole has no role in viral or common bacterial gastroenteritis 7
- Do not use antiperistaltic agents when CDI is suspected, as they may worsen outcomes 7